Staburo Wiesn-Workshop 2019

Nov 26, 2019
Staburo employees enjoying the Oktoberfest

It is a very nice custom to have our Staburo statistics training session on the first Monday of the two-week Oktoberfest period. This year, the Staburo team had the chance to learn about our new R shiny App in the first presentation “OTTO – Demonstration and Methodology”. OTTO stands for Optimal Tool for Tracking of Outliers. Afterwards we heard a talk about “Sample Size Calculation in Time-to-Event Trials with Non-Proportional Hazards Using GESTATE”, presented by our new colleague Jasmin.

After lunch, there where two more Talks, one about “Optimal Plate Layout for Relative Potency Estimation – A Simulation Study” and the last one from our new employee Armin about “Subgroup identification by generalized Patient Rule Induction Method (PRIM)”.

As always, this was a great opportunity to share knowledge with the whole Staburo team, get the chance to get to know the team better and to exchange ideas afterwards.

The second important custom is to pay the Oktoberfest (or also called “Wiesn”) a visit, after the workshop. Once again, we had a wonderful time with our growing team and some long-time Staburo clients.

Everyone got home safely – with additional knowledge from the workshop and positive vibes from the Oktoberfest. We are already looking forward to the Staburo “Wiesn” Workshop 2020 and thank all participants for making this a great team event!

More Articles

Health Day @ Staburo

Health Day @ Staburo

For the 4th time, Staburo Health Day took place and this year’s we focused on mindfulness and mental wellbeing, topics that are becoming increasingly important in today’s fast-moving work environment and in our everyday lives.

read more
Staburo Top Company 2026

Staburo Top Company 2026

We’re happy to share that Staburo has once again been awarded as Kununu Top Company 2026, and we’ve now received this recognition three years in a row (2024, 2025, 2026).

read more
Biomarkers at Staburo

Biomarkers at Staburo

In 2024 at Staburo was about building momentum in the area Biomarkers. Deepening our engagement in the PSI Biomarker SIG, strengthening collaborations, and developing the ideas that would later become deliverables. In 2025, we developed and released ShadowVIMP, an R...

read more